aDepartment of Cardiology, Copenhagen University Hospital - Herlev and Gentofte, Copenhagen, Denmark;
bDepartment of Nephrology, Copenhagen University Hospital - Herlev and Gentofte, Denmark;
cDepartment of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark;
dDepartment of Nephrology, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark;
eBrigham and Women’s Hospital, Harvard Medical School, Boston, MA;
fMRC Population Health Research Unit, Nuffield Department of Population Health, University of Oxford, UK;
gSteno Diabetes Center Copenhagen - Copenhagen University Hospital, Herlev, Denmark;
hDepartment of Cardiology, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark;
iUniversité de Lorraine, Inserm, Center d'Investigations Cliniques, - Plurithématique 14-33, and Inserm U1116, CHRU, F-CRIN INI-CRCT (Cardiovascular and Renal Clinical Trialists), Nancy, France.
*Tor Biering-Sørensen, MD, PhD, MPH, Center for Translational Cardiology and Pragmatic Randomized Trials, Cardiovascular Non-Invasive Imaging Research Laboratory, Department of Cardiology, Gentofte Hospitalsvej 8, 3 th, 2900 Hellerup, Denmark. E-mail: [email protected]
